 | • レポートコード：GIR-107A11848 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：産業機械＆装置 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ファーマコゲノミクス（PGx）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ファーマコゲノミクス（PGx）の種類別市場規模（ポリメラーゼ連鎖反応（PCR）、マイクロアレイ、シーケンシング、その他）、用途別市場規模（心血管疾患（CVD）、中枢神経系（CNS）、癌/腫瘍学、感染症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ファーマコゲノミクス（PGx）の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories、Affymetrix, Inc.、Assurex Health, Inc、Astrazeneca、GeneDX、Illumina, Inc.、Laboratory Corporation of America Holdings、Myriad Genetics, Inc.、Pathway Genomics、Pfizer, Inc、Qiagen, Inc.、Rocheg、Teva Pharmaceutical Industries Ltd.、Thermo Fisher Scientific、Transgenomic, Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ポリメラーゼ連鎖反応（PCR）、マイクロアレイ、シーケンシング、その他 ・用途別分析2016年-2026年：心血管疾患（CVD）、中枢神経系（CNS）、癌/腫瘍学、感染症、その他 ・ファーマコゲノミクス（PGx）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ファーマコゲノミクス（PGx）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ファーマコゲノミクス（PGx）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ファーマコゲノミクス（PGx）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ファーマコゲノミクス（PGx）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Pharmacogenomics (PGx) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pharmacogenomics (PGx) size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Pharmacogenomics (PGx) market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Pharmacogenomics (PGx) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Polymerase Chain Reaction (PCR)
Microarray
Sequencing
Other
Market segment by Application, can be divided into
Cardiovascular Diseases (CVD)
Central Nervous System (CNS)
Cancer/Oncology
Infectious Diseases
Other
Market segment by players, this report covers
Abbott Laboratories
Affymetrix, Inc.
Assurex Health, Inc
Astrazeneca
GeneDX
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
Pathway Genomics
Pfizer, Inc
Qiagen, Inc.
Rocheg
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
Transgenomic, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Pharmacogenomics (PGx)
1.2 Classification of Pharmacogenomics (PGx) by Type
1.2.1 Overview: Global Pharmacogenomics (PGx) Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Pharmacogenomics (PGx) Revenue Market Share by Type in 2020
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Microarray
1.2.5 Sequencing
1.2.6 Other
1.3 Global Pharmacogenomics (PGx) Market by Application
1.3.1 Overview: Global Pharmacogenomics (PGx) Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Cardiovascular Diseases (CVD)
1.3.3 Central Nervous System (CNS)
1.3.4 Cancer/Oncology
1.3.5 Infectious Diseases
1.3.6 Other
1.4 Global Pharmacogenomics (PGx) Market Size & Forecast
1.5 Global Pharmacogenomics (PGx) Market Size and Forecast by Region
1.5.1 Global Pharmacogenomics (PGx) Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Pharmacogenomics (PGx) Market Size by Region, (2016-2021)
1.5.3 North America Pharmacogenomics (PGx) Market Size and Prospect (2016-2026)
1.5.4 Europe Pharmacogenomics (PGx) Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Pharmacogenomics (PGx) Market Size and Prospect (2016-2026)
1.5.6 South America Pharmacogenomics (PGx) Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Pharmacogenomics (PGx) Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Pharmacogenomics (PGx) Market Drivers
1.6.2 Pharmacogenomics (PGx) Market Restraints
1.6.3 Pharmacogenomics (PGx) Trends Analysis
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Pharmacogenomics (PGx) Product and Solutions
2.1.4 Abbott Laboratories Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Affymetrix, Inc.
2.2.1 Affymetrix, Inc. Details
2.2.2 Affymetrix, Inc. Major Business
2.2.3 Affymetrix, Inc. Pharmacogenomics (PGx) Product and Solutions
2.2.4 Affymetrix, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Affymetrix, Inc. Recent Developments and Future Plans
2.3 Assurex Health, Inc
2.3.1 Assurex Health, Inc Details
2.3.2 Assurex Health, Inc Major Business
2.3.3 Assurex Health, Inc Pharmacogenomics (PGx) Product and Solutions
2.3.4 Assurex Health, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Assurex Health, Inc Recent Developments and Future Plans
2.4 Astrazeneca
2.4.1 Astrazeneca Details
2.4.2 Astrazeneca Major Business
2.4.3 Astrazeneca Pharmacogenomics (PGx) Product and Solutions
2.4.4 Astrazeneca Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Astrazeneca Recent Developments and Future Plans
2.5 GeneDX
2.5.1 GeneDX Details
2.5.2 GeneDX Major Business
2.5.3 GeneDX Pharmacogenomics (PGx) Product and Solutions
2.5.4 GeneDX Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 GeneDX Recent Developments and Future Plans
2.6 Illumina, Inc.
2.6.1 Illumina, Inc. Details
2.6.2 Illumina, Inc. Major Business
2.6.3 Illumina, Inc. Pharmacogenomics (PGx) Product and Solutions
2.6.4 Illumina, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Illumina, Inc. Recent Developments and Future Plans
2.7 Laboratory Corporation of America Holdings
2.7.1 Laboratory Corporation of America Holdings Details
2.7.2 Laboratory Corporation of America Holdings Major Business
2.7.3 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Product and Solutions
2.7.4 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
2.8 Myriad Genetics, Inc.
2.8.1 Myriad Genetics, Inc. Details
2.8.2 Myriad Genetics, Inc. Major Business
2.8.3 Myriad Genetics, Inc. Pharmacogenomics (PGx) Product and Solutions
2.8.4 Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Myriad Genetics, Inc. Recent Developments and Future Plans
2.9 Pathway Genomics
2.9.1 Pathway Genomics Details
2.9.2 Pathway Genomics Major Business
2.9.3 Pathway Genomics Pharmacogenomics (PGx) Product and Solutions
2.9.4 Pathway Genomics Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Pathway Genomics Recent Developments and Future Plans
2.10 Pfizer, Inc
2.10.1 Pfizer, Inc Details
2.10.2 Pfizer, Inc Major Business
2.10.3 Pfizer, Inc Pharmacogenomics (PGx) Product and Solutions
2.10.4 Pfizer, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Pfizer, Inc Recent Developments and Future Plans
2.11 Qiagen, Inc.
2.11.1 Qiagen, Inc. Details
2.11.2 Qiagen, Inc. Major Business
2.11.3 Qiagen, Inc. Pharmacogenomics (PGx) Product and Solutions
2.11.4 Qiagen, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Qiagen, Inc. Recent Developments and Future Plans
2.12 Rocheg
2.12.1 Rocheg Details
2.12.2 Rocheg Major Business
2.12.3 Rocheg Pharmacogenomics (PGx) Product and Solutions
2.12.4 Rocheg Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Rocheg Recent Developments and Future Plans
2.13 Teva Pharmaceutical Industries Ltd.
2.13.1 Teva Pharmaceutical Industries Ltd. Details
2.13.2 Teva Pharmaceutical Industries Ltd. Major Business
2.13.3 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Product and Solutions
2.13.4 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.14 Thermo Fisher Scientific
2.14.1 Thermo Fisher Scientific Details
2.14.2 Thermo Fisher Scientific Major Business
2.14.3 Thermo Fisher Scientific Pharmacogenomics (PGx) Product and Solutions
2.14.4 Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.15 Transgenomic, Inc.
2.15.1 Transgenomic, Inc. Details
2.15.2 Transgenomic, Inc. Major Business
2.15.3 Transgenomic, Inc. Pharmacogenomics (PGx) Product and Solutions
2.15.4 Transgenomic, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Transgenomic, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pharmacogenomics (PGx) Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Pharmacogenomics (PGx) Players Market Share
3.2.2 Top 10 Pharmacogenomics (PGx) Players Market Share
3.2.3 Market Competition Trend
3.3 Pharmacogenomics (PGx) Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Pharmacogenomics (PGx) Revenue and Market Share by Type (2016-2021)
4.2 Global Pharmacogenomics (PGx) Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Pharmacogenomics (PGx) Revenue Market Share by Application (2016-2021)
5.2 Pharmacogenomics (PGx) Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Pharmacogenomics (PGx) Revenue by Type (2016-2026)
6.2 North America Pharmacogenomics (PGx) Revenue by Application (2016-2026)
6.3 North America Pharmacogenomics (PGx) Market Size by Country
6.3.1 North America Pharmacogenomics (PGx) Revenue by Country (2016-2026)
6.3.2 United States Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
6.3.3 Canada Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
6.3.4 Mexico Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Pharmacogenomics (PGx) Revenue by Type (2016-2026)
7.2 Europe Pharmacogenomics (PGx) Revenue by Application (2016-2026)
7.3 Europe Pharmacogenomics (PGx) Market Size by Country
7.3.1 Europe Pharmacogenomics (PGx) Revenue by Country (2016-2026)
7.3.2 Germany Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
7.3.3 France Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
7.3.5 Russia Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
7.3.6 Italy Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Pharmacogenomics (PGx) Revenue by Type (2016-2026)
8.2 Asia-Pacific Pharmacogenomics (PGx) Revenue by Application (2016-2026)
8.3 Asia-Pacific Pharmacogenomics (PGx) Market Size by Region
8.3.1 Asia-Pacific Pharmacogenomics (PGx) Revenue by Region (2016-2026)
8.3.2 China Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
8.3.3 Japan Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
8.3.4 South Korea Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
8.3.5 India Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
8.3.7 Australia Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Pharmacogenomics (PGx) Revenue by Type (2016-2026)
9.2 South America Pharmacogenomics (PGx) Revenue by Application (2016-2026)
9.3 South America Pharmacogenomics (PGx) Market Size by Country
9.3.1 South America Pharmacogenomics (PGx) Revenue by Country (2016-2026)
9.3.2 Brazil Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
9.3.3 Argentina Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Pharmacogenomics (PGx) Revenue by Type (2016-2026)
10.2 Middle East & Africa Pharmacogenomics (PGx) Revenue by Application (2016-2026)
10.3 Middle East & Africa Pharmacogenomics (PGx) Market Size by Country
10.3.1 Middle East & Africa Pharmacogenomics (PGx) Revenue by Country (2016-2026)
10.3.2 Turkey Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
10.3.4 UAE Pharmacogenomics (PGx) Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Pharmacogenomics (PGx) Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Pharmacogenomics (PGx) Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Pharmacogenomics (PGx) Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Pharmacogenomics (PGx) Revenue (USD Million) by Region (2016-2021)
Table 5. Global Pharmacogenomics (PGx) Revenue Market Share by Region (2021-2026)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Pharmacogenomics (PGx) Product and Solutions
Table 9. Abbott Laboratories Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Affymetrix, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Affymetrix, Inc. Major Business
Table 12. Affymetrix, Inc. Pharmacogenomics (PGx) Product and Solutions
Table 13. Affymetrix, Inc. Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Assurex Health, Inc Corporate Information, Head Office, and Major Competitors
Table 15. Assurex Health, Inc Major Business
Table 16. Assurex Health, Inc Pharmacogenomics (PGx) Product and Solutions
Table 17. Assurex Health, Inc Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Astrazeneca Corporate Information, Head Office, and Major Competitors
Table 19. Astrazeneca Major Business
Table 20. Astrazeneca Pharmacogenomics (PGx) Product and Solutions
Table 21. Astrazeneca Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. GeneDX Corporate Information, Head Office, and Major Competitors
Table 23. GeneDX Major Business
Table 24. GeneDX Pharmacogenomics (PGx) Product and Solutions
Table 25. GeneDX Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Illumina, Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Illumina, Inc. Major Business
Table 28. Illumina, Inc. Pharmacogenomics (PGx) Product and Solutions
Table 29. Illumina, Inc. Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Laboratory Corporation of America Holdings Corporate Information, Head Office, and Major Competitors
Table 31. Laboratory Corporation of America Holdings Major Business
Table 32. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Product and Solutions
Table 33. Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Myriad Genetics, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Myriad Genetics, Inc. Major Business
Table 36. Myriad Genetics, Inc. Pharmacogenomics (PGx) Product and Solutions
Table 37. Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Pathway Genomics Corporate Information, Head Office, and Major Competitors
Table 39. Pathway Genomics Major Business
Table 40. Pathway Genomics Pharmacogenomics (PGx) Product and Solutions
Table 41. Pathway Genomics Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Pfizer, Inc Corporate Information, Head Office, and Major Competitors
Table 43. Pfizer, Inc Major Business
Table 44. Pfizer, Inc Pharmacogenomics (PGx) Product and Solutions
Table 45. Pfizer, Inc Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Qiagen, Inc. Corporate Information, Head Office, and Major Competitors
Table 47. Qiagen, Inc. Major Business
Table 48. Qiagen, Inc. Pharmacogenomics (PGx) Product and Solutions
Table 49. Qiagen, Inc. Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Rocheg Corporate Information, Head Office, and Major Competitors
Table 51. Rocheg Major Business
Table 52. Rocheg Pharmacogenomics (PGx) Product and Solutions
Table 53. Rocheg Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Teva Pharmaceutical Industries Ltd. Corporate Information, Head Office, and Major Competitors
Table 55. Teva Pharmaceutical Industries Ltd. Major Business
Table 56. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Product and Solutions
Table 57. Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 59. Thermo Fisher Scientific Major Business
Table 60. Thermo Fisher Scientific Pharmacogenomics (PGx) Product and Solutions
Table 61. Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Transgenomic, Inc. Corporate Information, Head Office, and Major Competitors
Table 63. Transgenomic, Inc. Major Business
Table 64. Transgenomic, Inc. Pharmacogenomics (PGx) Product and Solutions
Table 65. Transgenomic, Inc. Pharmacogenomics (PGx) Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global Pharmacogenomics (PGx) Revenue (USD Million) by Players (2019-2021)
Table 67. Global Pharmacogenomics (PGx) Revenue Share by Players (2019-2021)
Table 68. Breakdown of Pharmacogenomics (PGx) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Pharmacogenomics (PGx) Players Head Office, Products and Services Provided
Table 70. Pharmacogenomics (PGx) Mergers & Acquisitions in the Past Five Years
Table 71. Pharmacogenomics (PGx) New Entrants and Expansion Plans
Table 72. Global Pharmacogenomics (PGx) Revenue (USD Million) by Type (2016-2021)
Table 73. Global Pharmacogenomics (PGx) Revenue Share by Type (2016-2021)
Table 74. Global Pharmacogenomics (PGx) Revenue Forecast by Type (2021-2026)
Table 75. Global Pharmacogenomics (PGx) Revenue by Application (2016-2021)
Table 76. Global Pharmacogenomics (PGx) Revenue Forecast by Application (2021-2026)
Table 77. North America Pharmacogenomics (PGx) Revenue by Type (2016-2021) & (USD Million)
Table 78. North America Pharmacogenomics (PGx) Revenue by Type (2021-2026) & (USD Million)
Table 79. North America Pharmacogenomics (PGx) Revenue by Application (2016-2021) & (USD Million)
Table 80. North America Pharmacogenomics (PGx) Revenue by Application (2021-2026) & (USD Million)
Table 81. North America Pharmacogenomics (PGx) Revenue by Country (2016-2021) & (USD Million)
Table 82. North America Pharmacogenomics (PGx) Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe Pharmacogenomics (PGx) Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe Pharmacogenomics (PGx) Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe Pharmacogenomics (PGx) Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe Pharmacogenomics (PGx) Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe Pharmacogenomics (PGx) Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe Pharmacogenomics (PGx) Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific Pharmacogenomics (PGx) Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific Pharmacogenomics (PGx) Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Pharmacogenomics (PGx) Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific Pharmacogenomics (PGx) Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Pharmacogenomics (PGx) Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific Pharmacogenomics (PGx) Revenue by Region (2021-2026) & (USD Million)
Table 95. South America Pharmacogenomics (PGx) Revenue by Type (2016-2021) & (USD Million)
Table 96. South America Pharmacogenomics (PGx) Revenue by Type (2021-2026) & (USD Million)
Table 97. South America Pharmacogenomics (PGx) Revenue by Application (2016-2021) & (USD Million)
Table 98. South America Pharmacogenomics (PGx) Revenue by Application (2021-2026) & (USD Million)
Table 99. South America Pharmacogenomics (PGx) Revenue by Country (2016-2021) & (USD Million)
Table 100. South America Pharmacogenomics (PGx) Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa Pharmacogenomics (PGx) Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa Pharmacogenomics (PGx) Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Pharmacogenomics (PGx) Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa Pharmacogenomics (PGx) Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Pharmacogenomics (PGx) Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa Pharmacogenomics (PGx) Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Pharmacogenomics (PGx) Picture
Figure 2. Global Pharmacogenomics (PGx) Revenue Market Share by Type in 2020
Figure 3. Polymerase Chain Reaction (PCR)
Figure 4. Microarray
Figure 5. Sequencing
Figure 6. Other
Figure 7. Pharmacogenomics (PGx) Revenue Market Share by Application in 2020
Figure 8. Cardiovascular Diseases (CVD) Picture
Figure 9. Central Nervous System (CNS) Picture
Figure 10. Cancer/Oncology Picture
Figure 11. Infectious Diseases Picture
Figure 12. Other Picture
Figure 13. Global Pharmacogenomics (PGx) Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Pharmacogenomics (PGx) Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Pharmacogenomics (PGx) Revenue Market Share by Region (2016-2026)
Figure 16. Global Pharmacogenomics (PGx) Revenue Market Share by Region in 2020
Figure 17. North America Pharmacogenomics (PGx) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Pharmacogenomics (PGx) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Pharmacogenomics (PGx) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Pharmacogenomics (PGx) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Pharmacogenomics (PGx) Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Pharmacogenomics (PGx) Market Drivers
Figure 23. Pharmacogenomics (PGx) Market Restraints
Figure 24. Pharmacogenomics (PGx) Market Trends
Figure 25. Abbott Laboratories Recent Developments and Future Plans
Figure 26. Affymetrix, Inc. Recent Developments and Future Plans
Figure 27. Assurex Health, Inc Recent Developments and Future Plans
Figure 28. Astrazeneca Recent Developments and Future Plans
Figure 29. GeneDX Recent Developments and Future Plans
Figure 30. Illumina, Inc. Recent Developments and Future Plans
Figure 31. Laboratory Corporation of America Holdings Recent Developments and Future Plans
Figure 32. Myriad Genetics, Inc. Recent Developments and Future Plans
Figure 33. Pathway Genomics Recent Developments and Future Plans
Figure 34. Pfizer, Inc Recent Developments and Future Plans
Figure 35. Qiagen, Inc. Recent Developments and Future Plans
Figure 36. Rocheg Recent Developments and Future Plans
Figure 37. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Figure 38. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 39. Transgenomic, Inc. Recent Developments and Future Plans
Figure 40. Global Pharmacogenomics (PGx) Revenue Share by Players in 2020
Figure 41. Pharmacogenomics (PGx) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 42. Global Top 3 Players Pharmacogenomics (PGx) Revenue Market Share in 2020
Figure 43. Global Top 10 Players Pharmacogenomics (PGx) Revenue Market Share in 2020
Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 45. Global Pharmacogenomics (PGx) Revenue Share by Type in 2020
Figure 46. Global Pharmacogenomics (PGx) Market Share Forecast by Type (2021-2026)
Figure 47. Global Pharmacogenomics (PGx) Revenue Share by Application in 2020
Figure 48. Global Pharmacogenomics (PGx) Market Share Forecast by Application (2021-2026)
Figure 49. North America Pharmacogenomics (PGx) Sales Market Share by Type (2016-2026)
Figure 50. North America Pharmacogenomics (PGx) Sales Market Share by Application (2016-2026)
Figure 51. North America Pharmacogenomics (PGx) Revenue Market Share by Country (2016-2026)
Figure 52. United States Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Canada Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Mexico Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Europe Pharmacogenomics (PGx) Sales Market Share by Type (2016-2026)
Figure 56. Europe Pharmacogenomics (PGx) Sales Market Share by Application (2016-2026)
Figure 57. Europe Pharmacogenomics (PGx) Revenue Market Share by Country (2016-2026)
Figure 58. Germany Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. France Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. United Kingdom Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Russia Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Italy Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Asia-Pacific Pharmacogenomics (PGx) Sales Market Share by Type (2016-2026)
Figure 64. Asia-Pacific Pharmacogenomics (PGx) Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Pharmacogenomics (PGx) Revenue Market Share by Region (2016-2026)
Figure 66. China Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Japan Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South Korea Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. India Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Southeast Asia Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Australia Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. South America Pharmacogenomics (PGx) Sales Market Share by Type (2016-2026)
Figure 73. South America Pharmacogenomics (PGx) Sales Market Share by Application (2016-2026)
Figure 74. South America Pharmacogenomics (PGx) Revenue Market Share by Country (2016-2026)
Figure 75. Brazil Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Argentina Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Middle East and Africa Pharmacogenomics (PGx) Sales Market Share by Type (2016-2026)
Figure 78. Middle East and Africa Pharmacogenomics (PGx) Sales Market Share by Application (2016-2026)
Figure 79. Middle East and Africa Pharmacogenomics (PGx) Revenue Market Share by Country (2016-2026)
Figure 80. Turkey Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Saudi Arabia Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. UAE Pharmacogenomics (PGx) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Methodology
Figure 84. Research Process and Data Source
世界の薬理ゲノミクス（PGx）市場予測（～2024年）：企業別、地域別、種類・用途別 Pharmacogenomics is the study of the role of the genome in drug response. Its name reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs. Scope of the Report: The global Pharmacogenomics (PGx) market i…- 世界のポリメラーゼ連鎖反応技術市場 2021：企業別、地域別、種類・用途別 The Polymerase Chain Reaction Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界のレッドバイオテクノロジー市場予測（～2024年） Red biotechnology is also known as biopharmaceuticals. It involves the application of biotechnology to produce medicine and drugs. Scope of the Report: The global Red Biotechnology market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAG…
- 世界のポリメラーゼ連鎖反応（PCR）テスト市場予測（～2024年） Polymerase chain reaction (PCR) is a technology that has opened up new vistas for advances in life sciences research and molecular diagnostics due to its attributes, such as detection and quantification of DNA and RNA genetic materials. Scope of the Report: The global Polymerase Chain Reaction (PCR)…
- ポリメラーゼ連鎖反応消耗品の世界市場… Scope of the Report: The global Polymerase Chain Reaction Consumable market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especiall…